BOOTHBAY FUND MANAGEMENT, LLC - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$253,918
-58.5%
61,185
-51.9%
0.01%
-53.8%
Q2 2023$611,380
+133.4%
127,106
+97.0%
0.01%
+160.0%
Q1 2023$261,976
-22.9%
64,526
+2.6%
0.01%
-37.5%
Q4 2022$339,741
-45.9%
62,915
+0.5%
0.01%
-50.0%
Q3 2022$628,000
+946.7%
62,580
+391.7%
0.02%
+700.0%
Q2 2022$60,00012,7270.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders